Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Drug Monitoring guided tamoxifen dosing: feasibility study
2017-005124-24Phase 4Completed
- Sponsor
- Erasmus MC Cancer Institute
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tamoxifen in breast cancer, sponsored by Erasmus MC Cancer Institute. Started Jan 2018; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2017-005124-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005124-24.